Depressive Symptoms as a Heterogeneous and Constantly Evolving Dynamical System: Idiographic Depressive Symptom Networks of Rapid Symptom Changes Among Persons With Major Depressive Disorder

被引:5
|
作者
Nemesure, Matthew D. [1 ,2 ,7 ]
Collins, Amanda C. [1 ,3 ,4 ]
Price, George D. [1 ,2 ]
Griffin, Tess Z. [1 ]
Pillai, Arvind [5 ]
Nepal, Subigya [5 ]
Heinz, Michael V. [1 ,3 ]
Lekkas, Damien [1 ]
Campbell, Andrew T. [1 ,5 ]
Jacobson, Nicholas C. [1 ,2 ,5 ,6 ]
机构
[1] Geisel Sch Med, Ctr Technol & Behav Hlth, Lebanon, NH USA
[2] Geisel Sch Med, Quantitat Biomed Sci, Hanover, NH USA
[3] Dartmouth Hitchcock Med Ctr, Dept Psychiat, Dartmouth, England
[4] Mississippi State Univ, Dept Psychol, Starkville, MS USA
[5] Dartmouth Coll, Dept Comp Sci, Dartmouth, MA USA
[6] Geisel Sch Med, Dept Biomed Data Sci, Lebanon, NH USA
[7] Harvard Sch Business, Digital Data Design Inst, Boston, MA 02163 USA
来源
关键词
major depressive disorder; ecological momentary assessment; time series; network analysis; symptom dynamics; MODEL;
D O I
10.1037/abn0000884
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Major depressive disorder (MDD) is conceptualized by individual symptoms occurring most of the day for at least two weeks. Despite this operationalization, MDD is highly variable with persons showing greater variation within and across days. Moreover, MDD is highly heterogeneous, varying considerably across people in both function and form. Recent efforts have examined MDD heterogeneity byinvestigating how symptoms influence one another over time across individuals in a system; however, these efforts have assumed that symptom dynamics are static and do not dynamically change over time. Nevertheless, it is possible that individual MDD system dynamics change continuously across time. Participants (N = 105) completed ratings of MDD symptoms three times a day for 90 days, and we conducted time varying vector autoregressive models to investigate the idiographic symptom networks. We then illustrated this finding with a case series of five persons with MDD. Supporting prior research, results indicate there is high heterogeneity across persons as individual network composition is unique from person to person. In addition, for most persons, individual symptom networks change dramatically across the 90 days, as evidenced by 86% of individuals experiencing at least one change in their most influential symptom and the median number of shifts being 3 over the 90 days. Additionally, most individuals had at least one symptom that acted as both the most and least influential symptom at any given point over the 90-day period. Our findings offer further insight into short-term symptom dynamics, suggesting that MDD is heterogeneous both across and within persons over time.
引用
收藏
页码:155 / 166
页数:12
相关论文
共 50 条
  • [41] Changes in depressive symptoms among chronically ill older persons
    Penninx, BWJH
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 1999, 32 (02): : 35 - 35
  • [42] The relation between immunologic variables and symptom factors in patients with major depressive disorder
    Jeon, Yang-Whan
    Han, Sang-Ick
    Park, E. Jin
    ANNALS OF GENERAL PSYCHIATRY, 2018, 17
  • [43] Is the Noradrenergic Symptom Cluster a Valid Construct in Adjunctive Treatment of Major Depressive Disorder?
    Stauffer, Virginia L.
    Liu, Peng
    Goldberger, Celine
    Marangell, Lauren B.
    Nelson, Craig
    Gorwood, Philip
    Fava, Maurizio
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (03) : 317 - +
  • [44] Social anhedonia in major depressive disorder: a symptom-specific neuroimaging approach
    Verena Enneking
    Pia Krüssel
    Dario Zaremba
    Katharina Dohm
    Dominik Grotegerd
    Katharina Förster
    Susanne Meinert
    Christian Bürger
    Fanni Dzvonyar
    Elisabeth J. Leehr
    Joscha Böhnlein
    Jonathan Repple
    Nils Opel
    Nils R. Winter
    Tim Hahn
    Ronny Redlich
    Udo Dannlowski
    Neuropsychopharmacology, 2019, 44 : 883 - 889
  • [45] The symptom trajectories to clinical remission in Chinese patients with unipolar major depressive disorder
    Cao, Yuping
    Shen, Jingjin
    Li, Wen
    Zhang, Yu
    Guo, Xiaoyun
    Li, Chiang-shan
    Zhang, Yalin
    Luo, Xingguang
    ASIA-PACIFIC PSYCHIATRY, 2016, 8 (04) : 309 - 311
  • [46] Dehydroepiandrosterone Sulfate Level Varies Nonlinearly with Symptom Severity in Major Depressive Disorder
    Uh, Dasom
    Jeong, Hyun-Ghang
    Choi, Kwang-Yeon
    Oh, So-Young
    Lee, Suji
    Kim, Seung-Hyun
    Joe, Sook-Haeng
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2017, 15 (02) : 163 - 169
  • [47] Symptom Improvement and Regression After Multiple Ketamine Infusions in Major Depressive Disorder
    Vasu, Jordan
    Keilp, John G.
    Grunebaum, Michael F.
    Zanderigo, Francesca
    Mann, J. John
    Miller, Jeffrey
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S201 - S202
  • [48] Diagnosing major depressive disorder: II. Is there justification for compound symptom criteria?
    Zimmerman, M
    McGlinchey, JB
    Young, D
    Chelminski, I
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2006, 194 (04) : 235 - 240
  • [49] Psychosocial and Clinical Predictors of Symptom Persistence vs Remission in Major Depressive Disorder
    Enns, Murray W.
    Cox, Brian J.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (12): : 769 - 777
  • [50] Dehydroepiandrosterone sulfate level varies nonlinearly with symptom severity in major depressive disorder
    Kim, S. H.
    Yi, J. S.
    Kim, J. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S394 - S394